HDAC9 and acute lymphoblastic leukemia: DEqMS analysis identified MEF2C and HDAC9 among the top differentially abundant proteins in comparison to the other BCP-ALL cell lines (Fig. 6b, Supplementary Fig. 6b, and Supplementary Data 16), suggesting they may also be sensitive to the broad class I HDAC inhibitors.